Explore the Program by Day

Thursday, November 3, 2022
SessionsTimeSpeaker
Registration Open1:30 PM- 7:00 PM
KCA Think Tank Meeting (by Invitation Only)2:00 PM- 5:00 PM
Welcome and First Time Attendee Happy Hour (In-person Only)5:00 PM- 6:00 PM
Non-CME Industry Symposium6:00 PM- 7:00 PM
Non-CME Industry Symposium 6:00 PM- 7:00 PM
Friday, November 4, 2022
SessionsTimeSpeaker
Registration Open6:30 AM- 6:00 PM
Poster and Exhibit Hall Open6:30 AM6:30 PM
Women in RCC Networking (In-person Only)7:00 AM- 7:45 AM
Break7:45 AM- 8:00 AM
Welcome to 2022 IKCS: North America8:00 AM- 8:10 AMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Tian Zhang, MD, MHS
University of Texas Southwestern Medical Center
Welcome and Session 1: Treatment Debates8:10 AM- 10:00 AMVitaly Margulis, MD
University of Texas Southwestern Medical Center

Rana McKay, MD
University of California, San Diego
Debate 1: Surveillance vs Intervention8:10 AM- 8:45 AMPhillip M. Pierorazio, MD
Penn Presbyterian Medical Center, Penn Medicine

Raquib Hannan, MD, PhD
University of Texas Southwestern Medical Center
Debate 2: Doublet or Triplet as first-line Treatment in Kidney Cancer8:45 AM- 9:20 AMYousef Zakharia, MD
University of Iowa

Rana McKay, MD
University of California, San Diego
Debate 3: Adjuvant or Not? 9:20 AM- 10:00 AMBradley McGregor, MD
Dana-Farber Cancer Institute

Naomi Haas, MD
Penn Medicine
Session 2: Side-effect Management and Quality of Life Perspectives in Kidney Cancer Treatment10:00 AM- 11:00 AMKiran Virdee, RN CCRN-K
Memorial Sloan Kettering Cancer Center
Disease and Symptom Management, Supportive Care Options, and Understanding Patient-reported Outcomes10:00 AM- 10:20 AMElizabeth Wulff-Burchfield, MD
University of Kansas Medical Center
The Patient Perspective on Side-effects and Care10:20 AM- 10:25 AMLaura Esfeller
Daily Aspects of Side-effect Management Logistics10:25 AM- 10:35 AMKiran Virdee, RN CCRN-K
Memorial Sloan Kettering Cancer Center
Multidisciplinary Panel Discussion and Q+A: Navigating Renal Cell Carcinoma Side-effects Beyond Urology and Oncology10:35 AM- 11:00 AMKiran Virdee, RN CCRN-K
Memorial Sloan Kettering Cancer Center

Elizabeth Wulff-Burchfield, MD
University of Kansas Medical Center

Yan Liu, MD, PhD
Ascension Texas Cardiovascular

TBD

TBD
Break11:00 AM- 11:30 AM
Session 3: The Professional State of RCC11:30 AM- 11:50 AMW. Kimryn Rathmell, MD, PhD
Vanderbilt University Medical Center
The Professional State of RCC11:30 AM- 11:50 AM
Session 4: Professional Development Workshop (In-person Only)11:50 AM- 1:00 PMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Tian Zhang, MD, MHS
University of Texas Southwestern Medical Center
Introduction11:50 AM- 11:55 AMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Tian Zhang, MD, MHS
University of Texas Southwestern Medical Center
Breakout Group 1: Professional Development and What I Wish I’d Known 10 Years Earlier11:55 AM- 12:30 PMBradley C. Leibovich, MD
Mayo Clinic

Tian Zhang, MD, MHS
University of Texas Southwestern Medical Center

Daniel J. George, MD
Duke University
Breakout Group 2: Learning from Others’ Experience- How and When to Consider Career Moves11:55 AM- 12:30 PMBrian Rini, MD
Vanderbilt University Medical Center

Eric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Jodi Maranchie, MD
University of Pittsburgh Medical Center

W. Kimryn Rathmell, MD, PhD
Vanderbilt University Medical Center
Breakout Group 3: Career Opportunities in Industry and Options Outside of Academia11:55 AM- 12:30 PMSubramanian Hariharan, MD, FACP
Pfizer

Jose R. Perez, MD
Exelixis

Bradley McGregor, MD
Dana-Farber Cancer Institute
Bringing it Back Together: Insights from Breakout Group Discussions and Wrap-Up12:30 PM- 1:00 PM
Lunch and Poster Session 1:00 PM- 2:30 PM
Break1:00 PM- 1:15 PM
Non-CME Industry Symposium1:15 PM- 2:15 PM
Break2:15 PM- 2:30 PM
Session 5: Keynote Lecture2:30 PM- 3:15 PMTian Zhang, MD, MHS
University of Texas Southwestern Medical Center
Introduction2:30 PM- 2:35 PMTian Zhang, MD, MHS
University of Texas Southwestern Medical Center
Keynote Lecture2:35 PM- 3:00 PMTBD
Question and Answer3:00 PM- 3:15 PM
Session 6: Multidisciplinary Team Approaches to Rare Subtypes3:15 PM- 4:30 PMJodi Maranchie, MD
University of Pittsburgh Medical Center
Collecting Duct, Sarcomatoid, and Rhabdoid Subtypes3:15 PM- 3:27 PMDavid Braun, MD, PhD
Yale School of Medicine
Translocation Type Subtypes3:27 PM- 3:37 PMSrinivas R. Viswanathan, MD, PhD
Dana-Farber Cancer Institute
Renal Medullary Cancer3:37 PM- 3:47 PMPavlos Msaouel, MD, PhD
University of Texas MD Anderson Cancer Center
Best Practices for Multidisciplinary Care Teams Discussion and Panel Question and Answer3:47 PM- 4:30 PMPayal Kapur, MD
University of Texas Southwestern

Ivan Pedrosa, MD, PhD
University of Texas Southwestern

Steven Chang, MD, MS
Dana-Farber/ Brigham and Women’s Cancer Center

Stephanie Berg, DO
Loyola University

Chad Tang, MD
University of Texas MD Anderson Cancer Center
Session 7: Academy of Kidney Cancer Investigators4:30 PM- 5:15 PMBrian Rini, MD
Vanderbilt University Medical Center
Introduction4:30 PM- 4:35 PMBrian Rini, MD
Vanderbilt University Medical Center
Research Update 14:35 PM- 4:50 PMWenxin Xu, MD
Dana-Farber Cancer Institute
Research Update 24:50 PM- 5:05 PMPeter Ly, PhD
University of Texas Southwestern
Panel Discussion and Question and Answer5:05 PM- 5:15 PM
Networking Session: Evening Reception and Poster Session5:15 PM- 6:30 PM
Networking Session: Poster Walks (In-person)5:30 PM- 6:15 PMShawn Dason, MD
Ohio State University Medical Center

Sumanta “Monty” K. Pal, MD, FASCO
City of Hope
Networking Session: Poster Walks (Virtual)5:30 PM- 6:15 PMBradley McGregor, MD
Dana-Farber Cancer Institute

Phillip Pierorazio, MD
Penn Presbyterian Medical Center, Penn Medicine
Non-CME Industry Symposium6:00 PM- 7:00 PM
Saturday, November 5, 2022
SessionsTimeSpeaker
Early Morning Run (In-person only, Advance Registration Required)6:30 AM- 7:30 AMBradley McGregor, MD
Dana-Farber Cancer Institute
Early Morning Yoga (In-person only, Advance Registration Required)6:30 AM- 7:30 AMPhillip Pierorazio, MD
Penn Presbyterian Medical Center, Penn Medicine
Registration Open6:30 AM- 2:00 PM
Poster and Exhibit Hall Open6:30 AM- 2:00 PM
Non-CME Industry Symposium7:00 AM- 7:45 AM
Break7:45 AM- 8:00 AM
Day 2 Welcome and Updates from the Kidney Cancer Association8:00 AM- 8:15 AM
Kidney Cancer Association Initiatives, Progress, and New Horizons8:00 AM- 8:15 AMDaniel J. George, MD
Duke University
Session 8: Regulatory for New Trials8:15 AM- 9:15 AMSumanta “Monty” K. Pal, MD, FASCO
City of Hope
The New Era of Clinical Trials: Meeting Regulatory Requirements and Decreasing Barriers8:15 AM- 8:30 AMElaine Chang, MD
US Food and Drug Administration
Choosing Endpoints and Designs of Future Trials: OS vs PFS and Comparator Cohorts8:30 AM- 8:45 AMChung-Han “Joe” Lee, MD, PhD, BS
Memorial Sloan Kettering Cancer Center
Patient Perspectives and Differing Viewpoints of Clinical Trials as Part of Patient Care8:45 AM- 9:00 AMTBD
Panel Discussion and Question and Answer9:00 AM- 9:15 AM
Session 9: Oral Abstract Session9:15 AM- 10:00 AMYousef Zakharia, MD
University of Iowa
Break10:00 AM- 10:15 AM
Session 10: Genetics in Kidney Cancer Demonstrated Through Case-Based Presentations10:15 AM- 11:45 AMMaria Carlo, MD
Memorial Sloan Kettering Cancer Center
Who, What, When, Where, and Why of Genetics in Kidney Cancer: Considerations for the Genetics Consensus Statement10:15 AM- 10:35 AMMaria Carlo, MD
Memorial Sloan Kettering Cancer Center
Somatic Testing Considerations10:35 AM- 10:55 AMElizabeth “Lisa” Henske, MD
Brigham and Women’s Hospital
Genetics in the Scope of BHD, TSC-associated RCC, HLRCC, FH deficient RCC, and VHL10:55 AM- 11:15 AMRamprasad “Ram” Srinivasan, MD, PhD
National Cancer Institute at the National Institutes of Health
Panel Discussion and Question and Answer11:15 AM- 11:45 AM
Session 11: Risk Stratification: The Evolving State of RCC11:45 AM- 12:30 PMKaty Beckermann, MD, PhD
Vanderbilt University Medical Center
Using Proper Risk Stratification and How to do it Accurately11:45 AM- 12:00 PMDaniel Heng, MD, MPH, FRCPC
Tom Baker Cancer Centre
What’s Wrong with the Guidelines and How Do We Move Forward?12:00 PM- 12:15 PMA. Ari Hakimi, MD
Memorial Sloan Kettering Cancer Center
Panel Discussion and Question and Answer12:15 PM- 12:30 PM
Break and Lunch Available 12:30 PM- 1:30 PM
Session 12: Kidney Cancer Association Awards Recognition Ceremony12:45 PM- 1:15 PMBradley C. Leibovich, MD
Mayo Clinic
Presentation of the Eugene P. Schonfeld Award 12:45 PM- 12:55 PMDavid F. McDermott, MD
Beth Israel Deaconess
Presentation of the Christopher G. Wood Rising Star Award12:55 PM- 1:05 PMTBD
Presentation of the Kidney Cancer Association Humanitarian Award1:05 PM- 1:15 PMTBD
Session 13: WoodFire®
WoodFire® is an exciting chance to watch clinicians debate the various treatment options for each presented oncology case. It’s the fiercest tumor board you’ll ever see!
1:15 PM- 2:15 PM
Case Presentation and Discussion 11:15 PM- 1:30 PMWalter Stadler, MD
University of Chicago Comprehensive Cancer Center
Case Presentation and Discussion 21:30 PM- 1:45 PMRana McKay, MD
University of California, San Diego
Case Presentation and Discussion 31:45 PM- 2:00 PMVignesh Packiam, MD
University of Iowa
Case Presentation and Discussion 42:00 PM- 2:15 PMTBD
Meeting Adjourn2:15 PM- 2:30 PMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center